HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoya Asai Selected Research

Microfilament Proteins (Actin Binding Proteins)

11/2018Girdin/GIV regulates collective cancer cell migration by controlling cell adhesion and cytoskeletal organization.
8/2015Potential involvement of kinesin-1 in the regulation of subcellular localization of Girdin.
1/2012Involvement of Girdin in the determination of cell polarity during cell migration.
5/2011The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury.
3/2008An actin-binding protein Girdin regulates the motility of breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoya Asai Research Topics

Disease

23Neoplasms (Cancer)
08/2022 - 01/2002
5Neuroblastoma
08/2022 - 08/2006
3Carcinoma (Carcinomatosis)
01/2022 - 01/2002
3Schizophrenia (Dementia Praecox)
08/2015 - 09/2009
2Neoplasm Metastasis (Metastasis)
08/2022 - 03/2008
2Fibrosis (Cirrhosis)
01/2022 - 01/2021
2Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2021
2Myocardial Infarction
01/2019 - 11/2015
2Glioma (Gliomas)
12/2017 - 01/2017
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2016 - 10/2012
2Vascular Remodeling
08/2014 - 05/2011
2Breast Neoplasms (Breast Cancer)
05/2008 - 03/2008
1Colitis
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Adenocarcinoma of Lung
12/2020
1Lung Neoplasms (Lung Cancer)
12/2020
1Adenocarcinoma
10/2019
1Hypoxia (Hypoxemia)
01/2019
1Skin Neoplasms (Skin Cancer)
11/2018
1Glioblastoma (Glioblastoma Multiforme)
01/2017
1Brain Neoplasms (Brain Tumor)
01/2017
1Leukemia
01/2017
1Lymphatic Metastasis
02/2016
1Stomach Neoplasms (Stomach Cancer)
02/2016
1Infections
12/2015
1Hepatitis
12/2015
1Heart Rupture
11/2015
1Dehydration (Water Stress)
12/2014
1Hyperplasia
08/2014
1Pathologic Neovascularization
02/2013
1Choroidal Neovascularization
02/2013
1Ovarian Neoplasms (Ovarian Cancer)
10/2012
1Ovarian Epithelial Carcinoma
10/2012
1Hearing Loss (Hearing Impairment)
03/2012
1Portal Hypertension
01/2012
1Liver Diseases (Liver Disease)
01/2012
1Diabetes Insipidus
12/2011
1Glomerulonephritis
06/2011
1IGA Glomerulonephritis (IGA Nephropathy)
06/2011
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
06/2011

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2009
6Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
01/2022 - 10/2012
6Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
06/2011 - 01/2002
5CollagenIBA
01/2022 - 11/2015
5Microfilament Proteins (Actin Binding Proteins)IBA
11/2018 - 03/2008
3Glycoproteins (Glycoprotein)IBA
12/2020 - 10/2012
3Small Interfering RNA (siRNA)IBA
08/2014 - 08/2006
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2010 - 07/2005
3ParaffinIBA
10/2009 - 01/2002
2RNA (Ribonucleic Acid)IBA
01/2022 - 03/2008
2Serine (L-Serine)FDA Link
11/2015 - 05/2011
2Vasopressins (Vasopressin)IBA
12/2014 - 12/2011
2IntegrinsIBA
05/2014 - 10/2009
2Cisplatin (Platino)FDA LinkGeneric
05/2014 - 04/2009
2Tyrosine (L-Tyrosine)FDA Link
03/2012 - 07/2010
2Biological ProductsIBA
01/2012 - 05/2008
2Formaldehyde (Formol)FDA Link
10/2009 - 05/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2006 - 01/2002
1Phosphates (Orthophosphate)IBA
08/2022
1BuffersIBA
08/2022
1SolutionsIBA
08/2022
1polyphyllin DIBA
08/2022
1Bromodeoxyuridine (BrdU)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Bone Morphogenetic Protein 7IBA
01/2022
1Complement Factor D (Factor D)IBA
08/2021
1AdipokinesIBA
08/2021
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Leucine (L-Leucine)FDA Link
01/2021
1ElastinIBA
01/2021
1Collagen Type I (Type I Collagen)IBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1Cadherins (E-Cadherin)IBA
11/2018
1GelsIBA
11/2018
1CateninsIBA
11/2018
1Temozolomide (Temodar)FDA LinkGeneric
12/2017
1Mechanistic Target of Rapamycin Complex 1IBA
01/2017
1Laminin (Merosin)IBA
02/2016
1Extracellular Matrix ProteinsIBA
02/2016
1DNA (Deoxyribonucleic Acid)IBA
12/2015
1KinesinsIBA
08/2015
1Transcription Factors (Transcription Factor)IBA
12/2014
1atelocollagenIBA
08/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013
1Oxygen (Dioxygen)IBA
02/2013
1Retinaldehyde (Retinal)IBA
02/2013
1taxaneIBA
10/2012
1Paclitaxel (Taxol)FDA LinkGeneric
10/2012
1Carboplatin (JM8)FDA LinkGeneric
10/2012
1PlatinumIBA
10/2012
1SteroidsIBA
01/2012
1Arginine Vasopressin (Argipressin)IBA
12/2011

Therapy/Procedure

9Therapeutics
01/2022 - 03/2005
1Isogeneic Transplantation
10/2019
1Lasers (Laser)
02/2013
1Drug Therapy (Chemotherapy)
10/2012